Exitel Plus Tablets for Dogs

Država: Irska

Jezik: engleski

Izvor: HPRA (Health Products Regulatory Authority)

Aktivni sastojci:

Praziquantel; Pyrantel embonate ; Febantel

Dostupno od:

Chanelle Pharmaceuticals Manufacturing Limited

ATC koda:

QP52AA51

INN (International ime):

Praziquantel; Pyrantel embonate ; Febantel

Doziranje:

50,50,150 mg/tablet

Farmaceutski oblik:

Tablet

Tip recepta:

CAM: Companion Animal Medicine as defined in relevant national legislation

Terapijska grupa:

Dogs

Područje terapije:

praziquantel, combinations

Terapijske indikacije:

Endoparasiticide

Status autorizacije:

Authorised

Datum autorizacije:

2009-03-20

Svojstava lijeka

1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Exitel Plus Tablets For Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Praziquantel
50 mg
Pyrantel
50 mg (equivalent to 144 mg pyrantel embonate)
Febantel
150 mg
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND
OTHER CONSTITUENTS
Lactose monohydrate
Microcrystalline cellulose
Magnesium stearate
Colloidal anhydrous silica
Croscarmellose sodium
Sodium laurilsulfate
Pork flavour
A pale yellow tablet with a cross breakline on one side.
The tablets can be divided into 2 or 4 equal parts.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Dogs.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
Treatment of mixed infections by nematodes and cestodes of the
following species
NEMATODES:
ASCARIDS:
_Toxocara canis, Toxascaris leonina_
(adult and late immature forms).
HOOKWORMS:
_Uncinaria stenocephala, Ancylostoma caninum_
(adults).
WHIPWORMS:
_Trichuris vulpis_
(adults).
CESTODES:
TAPEWORMS:
_Echinococcus species (E. granulosus, E. multilocularis), Taenia
species _
_(T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum_
(adult and immature forms).
3.3
CONTRAINDICATIONS
Do not use simultaneously with piperazine compounds.
Do not use in cases of hypersensitivity to the active substances or to
any of the excipients.
3.4
SPECIAL WARNINGS
2
Fleas serve as intermediate hosts for one common type of tapeworm –
_Dipylidium caninum_
.
Tapeworm infestation is certain to reoccur unless control of
intermediate hosts such as fleas, mice, etc.
is undertaken.
Tapeworm infestation is unlikely in pups less than 6 weeks of age.
Parasite resistance to any particular class of anthelmintic may
develop following frequent, repeated
use of an anthelmintic of that class.
Unnecessary use of antiparasitics or use deviating from the
instructions given in the SPC may increase
the resistance selection pressure and lead to reduced efficacy. The
decision to use the product should
be based on confirmation of the parasitic species and burden, or of
the risk of